Open Orphan PLC - London-based research organisation testing infectious and respiratory disease products - Confirms that it is helping the relevant Irish authorities with an allegation of potential insider trading dealing in the company's shares in 2020. Open Orphan says trading in the company's shares was undertaken by an "unconnected private individual". It said "there are no implications for the company in the resolution of this allegation and confirms that no employee, executive, director or anyone connected with the company had any involvement whatsoever in this matter nor are they suspected of any wrongdoing."
Current stock price: 9.67 pence, up 9.8%
12-month change: down 61%
By Chris Dorrell; chrisdorrell@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
